These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29849166)

  • 81. Does needle size matter? Effects of micro-hypodermic needle injections of botulinum toxin type A in patients with hemifacial spasm.
    Maytharakcheep S; Phokaewvarangkul O; Bhidayasiri R
    Parkinsonism Relat Disord; 2024 Jan; 118():105950. PubMed ID: 38081119
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A Review of Tolerance and Safety Profiles of Long-Term Botulinum Neurotoxin Type A in Asian Patients with Hemifacial Spasm and Benign Essential Blepharospasm.
    Lai KKH; Tsang A; Kuk AKT; Ko CKL; Chan E; Ko STC
    Neuroophthalmology; 2021; 45(5):293-300. PubMed ID: 34566211
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effect of botulinum toxin type a on tear production after treatment of lateral canthal rhytids.
    Arat YO; Yen MT
    Ophthalmic Plast Reconstr Surg; 2007; 23(1):22-4. PubMed ID: 17237684
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Therapeutic Approach to Botulinum Injections for Hemifacial Spasm, Synkinesis and Blepharospasm.
    Yahalom G; Janah A; Rajz G; Eichel R
    Toxins (Basel); 2022 May; 14(5):. PubMed ID: 35622608
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A Review of Periocular Botulinum Neurotoxin on the Tear Film Homeostasis and the Ocular Surface Change.
    Ho RW; Fang PC; Chang CH; Liu YP; Kuo MT
    Toxins (Basel); 2019 Jan; 11(2):. PubMed ID: 30678375
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Coexistent blepharospasm and hemifacial spasm: overlapping pathophysiologic mechanism?
    Tan EK; Chan LL; Koh KK
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):494-6. PubMed ID: 14966174
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies.
    Tambasco N; Filidei M; Nigro P; Parnetti L; Simoni S
    Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941718
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Botulinum toxin type B in blepharospasm and hemifacial spasm.
    Colosimo C; Chianese M; Giovannelli M; Contarino MF; Bentivoglio AR
    J Neurol Neurosurg Psychiatry; 2003 May; 74(5):687. PubMed ID: 12700325
    [No Abstract]   [Full Text] [Related]  

  • 89. Effect of previous botulinum neurotoxin treatment on microvascular decompression for hemifacial spasm.
    Wang X; Thirumala PD; Shah A; Gardner P; Habeych M; Crammond DJ; Balzer J; Horowitz M
    Neurosurg Focus; 2013 Mar; 34(3):E3. PubMed ID: 23452316
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Dysport (botulinum toxin type A) in routine therapeutic usage: a telephone needs assessment survey of European physicians to evaluate current awareness and adherence to product labeling changes.
    Hubble J; Schwab J; Hubert C; Abbott CC
    Clin Neuropharmacol; 2013; 36(4):122-7. PubMed ID: 23783005
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A comparative study of tear secretion in blepharospasm and hemifacial spasm patients treated with botulinum toxin.
    Price J; O'Day J
    J Clin Neuroophthalmol; 1993 Mar; 13(1):67-71. PubMed ID: 8501266
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years.
    Sorgun MH; Yilmaz R; Akin YA; Mercan FN; Akbostanci MC
    J Clin Neurosci; 2015 Aug; 22(8):1319-25. PubMed ID: 26100157
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Botulinum Toxins for Treating Essential Blepharospasm and Hemifacial Spasm.
    Ozzello DJ; Giacometti JN
    Int Ophthalmol Clin; 2018; 58(1):49-61. PubMed ID: 29239877
    [No Abstract]   [Full Text] [Related]  

  • 95. Comparison of Two Botulinum Neurotoxin A Injection Patterns with or without the Medial Lower Eyelid in the Treatment of Blepharospasm.
    Yang H; Lu J; Zhao X; Ding X; Wang Z; Cai X; Luo Y; Lu L
    J Ophthalmol; 2016; 2016():5957812. PubMed ID: 26885381
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effects of Tear Film Lipid Layer Thickness and Blinking Pattern on Tear Film Instability After Corneal Refractive Surgery.
    Chen Q; Li M; Yuan Y; Me R; Yu Y; Shi G; Wang X; Ke B
    Cornea; 2017 Jul; 36(7):810-815. PubMed ID: 28410354
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Ocular Surface Metrics in Blepharospasm Patients After Treatment With Botulinum Toxin Injections.
    Yabumoto C; Osaki MH; Osaki T; Gameiro GR; Campos M; Osaki TH
    Ophthalmic Plast Reconstr Surg; 2023 Sep-Oct 01; 39(5):475-478. PubMed ID: 36928309
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Botulinum toxin injection and tear production.
    Alsuhaibani AH; Eid SA
    Curr Opin Ophthalmol; 2018 Sep; 29(5):428-433. PubMed ID: 29994851
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results.
    Calace P; Cortese G; Piscopo R; Della Volpe G; Gagliardi V; Magli A; De Berardinis T
    Eur J Ophthalmol; 2003 May; 13(4):331-6. PubMed ID: 12872788
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Factors associated with quality of life in hemifacial spasm and blepharospasm during long-term treatment with botulinum toxin.
    Setthawatcharawanich S; Sathirapanya P; Limapichat K; Phabphal K
    Qual Life Res; 2011 Nov; 20(9):1519-23. PubMed ID: 21431990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.